Uncategorized Archives - Page 137 of 145

TuesdayAug 04, 2020 2:30 pm

Pets Could Harbor a Lot More Than Coronaviruses

The presence of SARS-COV-2 in cats and dogs has caught the attention of scientists. Many scientists have been researching whether the pets can transmit other pathogens, such as drug-resistant bacteria, to human beings. Effects of multidrug-resistant organisms crossing from pets to humans A puppy had exhibited some signs of the coronavirus in North Carolina after three people from the family that owned it had tested positive for the disease. There were concerns about whether the pup had contracted the disease or not. However, after testing samples, the results were negative, but other pets in the same household had tested positive…

TuesdayAug 04, 2020 10:00 am

How Synthetic Biology is Accelerating Drug Discovery

Synthetic biology is becoming an important tool in a wide range of applications. In the sector of drug discovery, there are many areas where synthetic biology has played a vital role in faster and accurate drug development at lower expenses. With an increased application of DNA sequencing, synthetic biology is becoming essential to biotech and pharma scientists. Furthermore, the tool has empowered drug discovery scientists to clone and synthesize DNA fragments to develop new drugs. Through it, researchers have resorted to automated platforms for rapid DNA synthesis. This technology is being looked at to generate more vaccine candidates for the…

MondayAug 03, 2020 2:55 pm

5 Trends Likely to Appear in Future Pharmaceuticals

The medical sector is rapidly acknowledging the benefits of digital health, though there is still some sluggishness in embracing those innovations. However, these innovations need to be adopted with the speed they require. Here are some of the trends that are likely to be seen in the pharmaceutical industry in the years to come. Digital health will revolve around the pill Most of the pharmaceutical industries are noting that it is not only adequate to produce and manufacture medicine. Future trends show that they should go past the natural appearance of the drug and come up with the complete package.…

MondayAug 03, 2020 11:50 am

Predictive Oncology Inc. (NASDAQ: POAI)’s TumorGenesis Presents at Precision in Drug Discovery & Preclinical Virtual Summit

TumorGenesis president Richard Gabriel selected to feature as keynote presenter at inaugural Drug Discovery & Preclinical Virtual Summit The summit features over 150 delegates from across bio-pharmaceutical industry coming together to market sector’s latest breakthroughs TumorGenesis, which specializes in creating laboratory-grown cancer cells directed towards ovarian cancer research, recently announced its first sale of cancer cell culture media to US university The global cell culture media market set to grow to over $2.4 billion per annum by 2024 Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and…

MondayAug 03, 2020 10:00 am

Medical Specialties Poised to Be Huge in Future

Sensors, artificial intelligence, and virtual reality are some of the advanced technologies that have changed the pharmaceutical sector, and many of these technologies will allow physicians to focus on what makes them good at treating patients. Digital health will also help doctors in performing some of the repetitive tasks that are always monotonous. However, with these six medical specialties, healthcare is poised to benefit greatly. General Practice Several doctors are choosing this specialty to make long term impacts on patients’ lives. Furthermore, general practice specialists boast a lot of trust from their patients. The GPs have also reduced the patient's…

FridayJul 31, 2020 3:00 pm

The Challenges of TB Detection

Mycobacteria tuberculosis complex (“MTBC”) is the pathogenic bacteria causing tuberculosis (“TB”). On the other hand, nontuberculous mycobacteria (“NTM”) is also another bacterium that has the potential to cause disease. Mycobacteria are organisms living in water, animal tissues, soil, and food sources. The organisms can conquer their hosts without showing any pathogenic signs and can cause serious infections. Infections by MTBC and NTM organisms have continued posing a lot of challenges to microbiologists and physicians globally. Their exclusive cell wall component prevents them from straining by a standard gram strain procedure. Worldwide TB Epidemic M.tuberculosis is the most common TB-causing bacterium…

FridayJul 31, 2020 9:30 am

6 Factors Fueling Antimicrobial Resistance

Drug resistance is a serious medical concern and poses a severe health threat in the medical fraternity. In this regard, antimicrobial resistance is one of the worst nightmares that most patients suffering from various infections continue to grapple with across the world. Generally, antimicrobial resistance results in adverse effects by bacterial infections leading to acute strain on the patient, which makes it challenging to treat. In this case, patients develop resistance against antimalarials, antifungals, and anthelmintic, among others. This article, therefore, discusses some of the factors that fuel antimicrobial resistance. Over-prescription of antibiotics This is one aspect that fuels antimicrobial…

ThursdayJul 30, 2020 2:45 pm

Could the COVID19 Crisis Be Compromising Research Quality?

Is the quality of research being compromised during the COVID-19 crisis? It is a question that should be asked by those who are involved in research expeditions. Research studies are crucial in coming up with discoveries; hence a lot of work ethics is always regarded. However, some loopholes may erupt, leading to some questions regarding the quality of research. Scrutinizing research exceptionalism The COVID-19 pandemic has continued to erode the norms of scientific research. As nations observe the ongoing efforts to understand and defeat theSARS-Cov2-Virus, clinical and laboratory studies have been conducted at supersonic speeds. Data has been generated in…

ThursdayJul 30, 2020 1:34 pm

DarioHealth Corp. (NASDAQ: DRIO) Platform Meets Patients’, Physicians’ Remote Care Needs Amid Pandemic

DarioHealth Corp. is a digital therapeutics innovator that supplies remote monitoring technology to caregivers and their patients The company’s Remote Patient Monitoring (“RPM”) technology reports patient data to care providers in the clinical setting and if necessary provides occasional “nudges” to patients to maintain their level of care DarioHealth began working in North America with two agreements announced in June, and in July began offering its solutions to the United Kingdom and Ireland thanks to a third agreement Such remote services have been increasingly in demand amid the ongoing global pandemic, regarded as a solution for minimizing the risk of…

ThursdayJul 30, 2020 12:17 pm

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Announces First Commercial Sale of Unique Ovarian-Cancer-Cell Media

POAI’s TumorGenesis inks deal with top-rated medical university in New England Predictive’s proprietary media allows researchers around the world to isolate, culture ovarian cancer cell types, leading to new targets for treatment The TumorGenesis media retain more than 95% of the DNA and RNA as well as crucial proteomic signatures Predictive Oncology (NASDAQ: POAI) has sold its first-ever commercial order of its novel ovarian cancer cell culture media for cancer cells collected from patient-derived samples (“PDx”) (http://ibn.fm/2xwl6). The sale, made through POAI’s subsidiary TumorGenesis working with distributor US Biological Corporation, marks a milestone for the knowledge-driven company, which is focused on…